Recovered · children with MAM
Summary of findings: Specially formulated foods probably leads to higher recovered compared with standard care (moderate certainty).
1 finding from 1 review
Not recovered · children with MAM
Summary of findings: Specially formulated foods showed no clear difference in not recovered compared with standard care (low certainty).
1 finding from 1 review
Defaulted · children with MAM
Summary of findings: Specially formulated foods probably leads to lower defaulted compared with standard care (moderate certainty).
1 finding from 1 review
Weight gain · children with MAM
1 finding from 1 review
WHZ final · children with MAM
1 finding from 1 review
MUAC gain · children with MAM
1 finding from 1 review
HAZ final · children with MAM
1 finding from 1 review
Relapse during intervention defined as admission to inpatient therapeutic care, remain wasted, and dropouts during intervention period · children aged 6 months‐5 years with SAM (and mixed HIV comorbidity), some of whom had been stabilised as inpatients pre‐trial
Standard ready‐to‐use therapeutic food (RUTF) leads to lower relapse during intervention defined as admission to inpatient… compared with RUTF using an alternative formulation (high certainty).
1 finding from 1 review
Mortality during intervention · children aged 6 months‐5 years with SAM (and mixed HIV comorbidity), some of whom had been stabilised as inpatients pre‐trial
Standard ready‐to‐use therapeutic food (RUTF) showed no clear difference in mortality during intervention compared with RUTF using an alternative formulation (moderate certainty).
1 finding from 1 review
Rate of weight gain (g/kg/day) · children aged 6 months‐5 years with SAM (and mixed HIV comorbidity), some of whom had been stabilised as inpatients pre‐trial
1 finding from 1 review
Recovery during intervention defined as weight gain ≥ 15% in relation to baseline weight, absence of complications and oedema, and MUAC > 110 mm in 2 studies; MUAC > 12.4 cm without oedema in 1 study; WHZ ≥ 80% for two consecutive visits in 1 stud... · children aged 6 months‐5 years with SAM (and mixed HIV comorbidity), some of whom had been stabilised as inpatients pre‐trial
Standard ready‐to‐use therapeutic food (RUTF) showed no clear difference in recovery during intervention defined as weight gain ≥ 15% in… compared with RUTF using an alternative formulation (high certainty).
1 finding from 1 review
Progression to SAM · children with MAM
Summary of findings: Lipid‐based nutrient supplements (full dose) showed no clear difference in progression to SAM compared with blended foods (full dose) (high certainty).
1 finding from 1 review
Has died · children with MAM
Summary of findings: Lipid‐based nutrient supplements (full dose) showed no clear difference in died compared with blended foods (full dose) (moderate certainty).
1 finding from 1 review
Defaulted · children with MAM
Summary of findings: Lipid‐based nutrient supplements (full dose) showed no clear difference in defaulted compared with blended foods (full dose) (moderate certainty).
1 finding from 1 review
Daily weight gain · children with MAM
1 finding from 1 review
WHZ gain · children with MAM
1 finding from 1 review
MUAC gain · children with MAM
1 finding from 1 review
Vomiting · children with MAM
Summary of findings: Lipid‐based nutrient supplements (full dose) may leads to higher vomiting compared with blended foods (full dose) (low certainty).
1 finding from 1 review
Recovered · children with MAM
Summary of findings: Lipid‐based nutrient supplements showed no clear difference in recovered compared with CSB++ (moderate certainty).
1 finding from 1 review
Progression to SAM · children with MAM
Summary of findings: Lipid‐based nutrient supplements showed no clear difference in progression to SAM compared with CSB++ (high certainty).
1 finding from 1 review